P. falciparum enhances HIV replication in an experimental malaria challenge system

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Orlov, Marika ^a,b   Vaida, Florin ^c   Finney, Olivia C ^a   Smith, David M ^b   Talley, Angela K ^a   Wang, Ruobing ^a   Kappe, Stefan H ^a   Deng, Qianqian ^b   Schooley, Robert T ^b   Duffy, Patrick E ^a,d  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; COCULTURE; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ERYTHROCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MALARIA FALCIPARUM; MIXED INFECTION; NONHUMAN; ORGANISMAL INTERACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM FALCIPARUM; PROVOCATION TEST; QUANTITATIVE STUDY; VIRUS REPLICATION;

CELLS, CULTURED; CHEMOKINE CCL3; COINFECTION; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; MALARIA; PLASMODIUM FALCIPARUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862740306     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039000     Document Type: Article

References (35)

1. Chandramohan D, Greenwood BM, (1998) Is there an interaction between human immunodeficiency virus and Plasmodium falciparum? Int J Epidemiol 27: 296-301.
2. Kalyesubula I, Musoke-Mudido P, Marum L, Bagenda D, Aceng E, et al. (1997) Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children. Pediatr Infect Dis J 16: 876-881.
3. Kapiga SH, Sam NE, Shao JF, Renjifo B, Masenga EJ, et al. (2002) HIV-1 epidemic among female bar and hotel workers in northern Tanzania: risk factors and opportunities for prevention. J Acquir Immune Defic Syndr 29: 409-417.
4. Mwapasa V, Rogerson SJ, Molyneux ME, Abrams ET, Kamwendo DD, et al. (2004) The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. AIDS 18: 1051-1059.
5. Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, et al. (2005) Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 365: 233-240.
6. Mermin J, Lule JR, Ekwaru JP, (2006) Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr 41: 129-130.
7. Grimwade K, French N, Mbatha DD, Zungu DD, Dedicoat M, et al. (2004) HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS 18: 547-554.
8. Abu-Raddad LJ, Patnaik P, Kublin JG, (2006) Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 314: 1603-1606.
9. Cuadros DF, Branscum AJ, Crowley PH, (2011) HIV-malaria co-infection: effects of malaria on the prevalence of HIV in East sub-Saharan Africa. Int J Epidemiol 40: 931-9.
10. Walther M, Woodruff J, Edele F, Jeffries D, Tongren JE, et al. (2006) Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J Immunol 177: 5736-5745.
11. Pantaleo G, Fauci AS, (1996) Immunopathogenesis of HIV infection. Annu Rev Microbiol 50: 825-854.
12. Chulay JD, Schneider I, Cosgriff TM, Hoffman SL, Ballou WR, et al. (1986) Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. Am J Trop Med Hyg 35: 66-68.
13. Hoffman SL, (1997) Experimental challenge of volunteers with malaria. Ann Intern Med 127: 233-235.
14. Epstein JE, Rao S, Williams F, Freilich D, Luke T, et al. (2007) Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. J Infect Dis 196: 145-154.
15. Angulo I, Fresno M, (2002) Cytokines in the pathogenesis of and protection against malaria. Clin Diagn Lab Immunol 9: 1145-1152.
16. Murray SM, Down CM, Boulware DR, Stauffer WM, Cavert WP, et al. (2010) Reduction of immune activation with chloroquine therapy during chronic HIV infection. J Virol 84: 12082-12086.
17. Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R, (2003) Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis 3: 722-727.
18. McCall MB, Roestenberg M, Ploemen I, Teirlinck A, Hopman J, et al. (2010) Memory-like IFN-gamma response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum. Eur J Immunol 40: 3472-3477.
19. Artavanis-Tsakonas K, Riley EM, (2002) Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes. J Immunol 169: 2956-2963.
20. Sinha S, Mishra SK, Sharma S, Patibandla PK, Mallick PK, et al. (2008) Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar J 7: 13.
21. Hananantachai H, Patarapotikul J, Ohashi J, Naka I, Krudsood S, et al. (2007) Significant association between TNF-alpha (TNF) promoter allele (-1031C, -863C, and -857C) and cerebral malaria in Thailand. Tissue Antigens 69: 277-280.
22. Tchinda VH, Tadem AD, Tako EA, Tene G, Fogako J, et al. (2007) Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha. Acta Trop 102: 20-28.
23. Riddell LA, Pinching AJ, Hill S, Ng TT, Arbe E, et al. (2001) A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease. AIDS Res Hum Retroviruses 17: 789-797.
24. Yahi N, Baghdiguian S, Bolmont C, Fantini J, (1992) Inhibition of human immunodeficiency virus infection in human colon epithelial cells by recombinant interferon-gamma. Eur J Immunol 22: 2495-2499.
25. Xiao L, Owen SM, Rudolph DL, Lal RB, Lal AA, (1998) Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha. J Infect Dis 177: 437-445.
26. Urban BC, Roberts DJ, (2003) Inhibition of T cell function during malaria: implications for immunology and vaccinology. J Exp Med 197: 137-141.
27. Xu H, Wipasa J, Yan H, Zeng M, Makobongo MO, et al. (2002) The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection. J Exp Med 195: 881-892.
28. Struik SS, Riley EM, (2004) Does malaria suffer from lack of memory? Immunol Rev 201: 268-290.
29. Stephens R, Albano FR, Quin S, Pascal BJ, Harrison V, et al. (2005) Malaria-specific transgenic CD4(+) T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood 106: 1676-1684.
30. Wipasa J, Okell L, Sakkhachornphop S, Suphavilai C, Chawansuntati K, et al. (2011) Short-lived IFN-gamma effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity. PLoS Pathog 7: e1001281.
31. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, et al. (2009) Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361: 468-477.
32. Pombo DJ, Lawrence G, Hirunpetcharat C, Rzepczyk C, Bryden M, et al. (2002) Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 360: 610-617.
33. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, et al. (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature 417: 95-98.
34. Cummings JF, Spring MD, Schwenk RJ, Ockenhouse CF, Kester KE, et al. (2010) Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Vaccine 28: 5135-5144.
35. Bull M, Lee D, Stucky J, Chiu YL, Rubin A, et al. (2007) Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J Immunol Methods 322: 57-69.